Tudor Investment Corp’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $279K | Hold |
244,821
| – | – | ﹤0.01% | 3179 |
|
|
2025
Q4 | $308K | Hold |
244,821
| – | – | ﹤0.01% | 3030 |
|
|
2025
Q3 | $379K | Hold |
244,821
| – | – | ﹤0.01% | 2847 |
|
|
2025
Q2 | $323K | Hold |
244,821
| – | – | ﹤0.01% | 2848 |
|
|
2025
Q1 | $406K | Hold |
244,821
| – | – | ﹤0.01% | 2397 |
|
|
2024
Q4 | $360K | Hold |
244,821
| – | – | ﹤0.01% | 2463 |
|
|
2024
Q3 | $365K | Hold |
244,821
| – | – | ﹤0.01% | 2196 |
|
|
2024
Q2 | $306K | Hold |
244,821
| – | – | ﹤0.01% | 2006 |
|
|
2024
Q1 | $294K | Hold |
244,821
| – | – | ﹤0.01% | 1862 |
|
|
2023
Q4 | $370K | Hold |
244,821
| – | – | ﹤0.01% | 1944 |
|
|
2023
Q3 | $392K | Sell |
244,821
-95,070
| -28% | -$173K | ﹤0.01% | 1790 |
|
|
2023
Q2 | $738K | Hold |
339,891
| – | – | 0.01% | 1496 |
|
|
2023
Q1 | $496K | Sell |
339,891
-1,214
| -0.4% | -$1.56K | 0.01% | 1620 |
|
|
2022
Q4 | $426K | Hold |
341,105
| – | – | 0.01% | 1691 |
|
|
2022
Q3 | $645K | Buy |
341,105
+308,800
| +956% | +$730K | 0.01% | 1215 |
|
|
2022
Q2 | $82K | Buy |
32,305
+15,410
| +91% | +$44.9K | ﹤0.01% | 1935 |
|
|
2022
Q1 | $58K | Buy |
+16,895
| New | +$59.7K | ﹤0.01% | 1860 |
|
|
2021
Q3 | – | Sell |
-213,330
| Closed | -$864K | – | 2706 |
|
|
2021
Q2 | $864K | Buy |
213,330
+176,957
| +487% | +$694K | 0.02% | 923 |
|
|
2021
Q1 | $156K | Sell |
36,373
-126,952
| -78% | -$606K | ﹤0.01% | 1463 |
|
|
2020
Q4 | $645K | Buy |
163,325
+82,713
| +103% | +$345K | 0.02% | 858 |
|
|
2020
Q3 | $297K | Buy |
+80,612
| New | +$340K | 0.01% | 988 |
|
|
2019
Q4 | – | Sell |
-16,944
| Closed | -$35K | – | 1319 |
|
|
2019
Q3 | $35K | Buy |
+16,944
| New | +$34.6K | ﹤0.01% | 1038 |
|
|
2019
Q2 | – | Sell |
-85,189
| Closed | -$222K | – | 1278 |
|
|
2019
Q1 | $222K | Sell |
85,189
-48,328
| -36% | -$146K | 0.01% | 961 |
|
|
2018
Q4 | $402K | Sell |
133,517
-848
| -0.6% | -$2.88K | 0.01% | 669 |
|
|
2018
Q3 | $465K | Buy |
+134,365
| New | +$713K | 0.01% | 708 |
|
|
2017
Q2 | – | Sell |
-93,342
| Closed | -$747K | – | 1282 |
|
|
2017
Q1 | $747K | Buy |
+93,342
| New | +$786K | 0.02% | 501 |
|
|
2016
Q4 | – | Sell |
-36,248
| Closed | -$384K | – | 1556 |
|
|
2016
Q3 | $384K | Buy |
36,248
+9,075
| +33% | +$90.4K | 0.01% | 871 |
|
|
2016
Q2 | $254K | Buy |
+27,173
| New | +$276K | 0.01% | 1269 |
|
|
2016
Q1 | – | Sell |
-26,500
| Closed | -$266K | – | 1912 |
|
|
2015
Q4 | $266K | Sell |
26,500
-20,300
| -43% | -$203K | 0.01% | 1283 |
|
|
2015
Q3 | $394K | Sell |
46,800
-72,991
| -61% | -$966K | 0.01% | 924 |
|
|
2015
Q2 | $1.93M | Buy |
119,791
+81,654
| +214% | +$1.27M | 0.06% | 207 |
|
|
2015
Q1 | $540K | Buy |
+38,137
| New | +$496K | 0.02% | 689 |
|
|
2014
Q3 | – | Sell |
-13,145
| Closed | -$116K | – | 1461 |
|
|
2014
Q2 | $116K | Buy |
13,145
+892
| +7% | +$7.79K | ﹤0.01% | 1093 |
|
|
2014
Q1 | $114K | Buy |
+12,253
| New | +$107K | ﹤0.01% | 1110 |
|
Other funds holding OPK
RCMNY
VPM
VCM
WCM
Tudor Investment Corp's OPK Position: Q1 2026 in Review
Tudor Investment Corp held its Opko Health (OPK) position steady in Q1 2026 at 244,821 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #3179.
Tudor Investment Corp first reported a position in OPK in Q1 2014 and has held it in 34 quarters since. The position peaked at $1.93M in Q2 2015. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.
- Tudor Investment Corp held 244,821 shares of Opko Health worth $279K as of Q1 2026.
- Tudor Investment Corp left its Opko Health share count unchanged in Q1 2026.
- Opko Health made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #3179 holding.
- Tudor Investment Corp first reported a position in Opko Health in Q1 2014 and has held it in 34 quarters since.
- Tudor Investment Corp's Opko Health position peaked at $1.93M in Q2 2015.
- 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.
Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.